Search results
Alnylam is a leading biotech company that develops RNAi therapeutics to silence genes that cause or contribute to human disease. Learn about its science, pipeline, patients, and corporate responsibility.
- Pipeline
OUR PIPELINE. Through pioneering science and an unwavering...
- Careers
CAREERS AT ALNYLAM This Is YOUR Moment. This is the moment...
- Our Products
Find information about Alnylam's pharmaceutical products:...
- About Alnylam
Our Science Is Changing the Way Medicine Treats Disease TM....
- Investor Relations
Alnylam Pharmaceuticals Conference Call to Discuss HELIOS-B...
- Scientific Advisory Board
The following content may not be associated with Alnylam...
- Intellectual Property
Alnylam’s patent estate includes a large number of issued...
- Pipeline
2 days ago · About Alnylam Pharmaceuticals. Alnylam (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and prevalent diseases with unmet need. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful ...
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Alnylam is a biopharmaceutical company that develops RNAi-based medicines for genetic and other diseases. Learn about its history, science, vision, mission, and values.
2 days ago · Shares in Alnylam Pharmaceuticals jumped after the company said a drug to treat a rare genetic form of heart disease met its goals in a late-stage trial, opening up the possibility of billions of ...
2 days ago · Topline. Shares of Alnylam Pharmaceuticals rose by over 32%, the company’s largest single-day gain in nearly two years, after announcing its drug vutrisiran helped reduce the number of deaths ...
OUR PIPELINE. Through pioneering science and an unwavering commitment to patients, Alnylam has led the translation of the breakthrough discovery of RNA interference (RNAi) into an entirely new class of medicines that is disrupting disease. RNAi therapeutics represent an innovative, clinically validated approach to gene silencing.
People also ask
Who is Alnylam Pharmaceuticals?
What does Alnylam do?
Why did Alnylam Pharmaceuticals jump?
How does Alnylam treat rare diseases?
What is Alnylam doing now?
What does Alnylam mean?
.png?itok=-ptHSluh&q=Alnylam%20Pharmaceuticals&ck=D7D6446024D2FC67F131D351494F4801&idpp=rc&idpview=singleimage&form=rc2idp "Alnylam Pharmaceuticals1")
